Pain Neuroscience Education Combined With Cognition-targeted Motor Control Training

May 3, 2017 updated by: University Ghent

A Modern Neuroscience Approach to Chronic Spinal Pain: Pain Neuroscience Education Combined With Cognition-targeted Motor Control Training

Chronic spinal pain (CSP) includes chronic low back pain, failed back surgery, chronic whiplash associated disorders, chronic non-traumatic neck pain, etc. The current investigators and others have provided evidence for impaired motor control of spinal muscles in patients with CSP. In addition, there is increasing evidence that central mechanisms, i.e. hyperexcitability of the central nervous system and brain abnormalities (e.g. decreased brain matter density) play a role in CSP. Hence, treatments for CSP should not only address the spinal muscles and joints, but also the brain. Therefore, a modern neuroscience approach, comprising of pain neuroscience education followed by cognition-targeted motor control training, can be applied.

The scientific objective entails examining the effectiveness of the modern neuroscience approach vs. usual care evidence-based physiotherapy for reducing pain and improving functioning in Flemish patients with CSP. A secondary objective entails examining the effectiveness of the modern neuroscience approach vs. usual care evidence-based physiotherapy for altering brain's structure and function (magnetic Resonance Imaging) in Flemish patients with CSP. Therefore, a multi-center triple-blind randomized controlled trial will be conducted.

To comply with this scientific objective, 120 CSP patients will be recruited and subjected to the baseline assessment. The baseline assessment includes the assessment of pain (including symptoms of central sensitization and conditioned pain modulation), the assessment of restrictions in functioning, brain imaging, the evaluation of motor control and muscle properties, spinal mobility, and psychosocial correlates. Baseline analysis will provide descriptive statistics and will lead to calculate correlation between the different outcome measures and predictors of pain and dysfunctioning. In a next step, included patients will be randomized to the experimental or control group. Those in the experimental group will receive neuroscience education combined with cognition-targeted motor control training. Those in the control group will be subjected to a control intervention, including back/neck school and general exercises. After the neuroscience education has been given, the experimental subjects will fill in the neurophysiology of pain test. Several follow-up assessments will take place. Part of the assessment (functionality (PDI questionnaire) and psychosocial correlates (Pain Catastrophizing Scale (PCS), pain vigilance and awareness questionnaire (PVAQ), Tampa Scale for Kinesiophobia (TSK), Illness Perception Questionnaire revised (IPQ-R)) will be re-evaluated after the first 3 sessions. The complete 'baseline' assessment will be repeated in the month following the treatment complement, rounding up the short-term follow-up assessment. Six months after the baseline assessment, pain, functioning and psychological correlates are assessed in an intermediate online assessment. One year after baseline assessment the complete assessment is repeated for the last time, unless the intermediate assessment indicates that treatment effects are no longer present. Both short and long term treatment effects can be studied and predictors for therapy success can be unraveled. Also correlations between changes in different outcome measures can provide relevant and innovative information.

The proof of principal suggests a strong effect reported by large effect sizes for pain and disability compared to usual care.

Study Overview

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ghent, Belgium, 9000
        • Ghent University Hospital
      • Ghent, Belgium, 9000
        • Universiteit Gent (UGent), Faculty of Medicine and Health Sciences, Dpt. Of Rehabilitation Sciences and Physiotherapy, BE-9000 Gent (Belgium)
      • Jette, Belgium, 1090
        • Vrije Universiteit Brussel, Faculty of Physical Education & Physiotherapy, Dpt. of Rehabilitation Sciences & Physiotherapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Nonspecific spinal pain of at least 3 months' duration, at least 3 days per week
  • Aged between 18 and 65 years
  • Seeking care because of neck pain or low back pain
  • Living or working within a radius of 50 km around the therapy location
  • Not starting new treatments or medication and continuing their usual care 6 weeks prior to and during study participation (to obtain a steady state)
  • Nonspecific failed back surgery > 3 years are permitted
  • Not undertaking exercise (> 3 metabolic Equivalents) 3 days before the experiment
  • Refraining from analgesics 48h prior to assessments.
  • Abstaining from caffeine, alcohol or nicotine 24h prior to assessment

Exclusion Criteria:

  • Neuropathic pain
  • Chronic widespread pain
  • Being pregnant or having given birth in the preceding year
  • Contra-indications related to MRI imaging
  • History of specific spinal surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual care
usual care evidence-based physiotherapy
Arm 1 (i.e., the control group) will be subjected to a control intervention, including back/neck school and general exercises. 3 sessions of education (session 1: group session; session 2: online module; session 3: individual session) will be given by a physiotherapist, followed by 15 sessions of traditional physiotherapy and general exercises. The 18 sessions will be spread over a period of 3 months.
Experimental: modern neuroscience approach
Arm 2 (i.e., the experimental group) will receive pain neuroscience education (3 sessions of education), followed by 15 sessions of cognition-targeted motor control training (15 sessions). The 18 sessions will be spread over a period of 3 months.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessment (questionnaire)
Time Frame: at baseline
questionnaire: numerical rating scale (NRS), central sensitization inventory (CSI), medical outcomes short form 36 health service (SF-36)
at baseline
Pain assessment (physical testing)
Time Frame: at baseline
Physical testing: pressure pain threshold (PTT), cold pressor test (CPT)
at baseline
Functional assessment (questionnaires)
Time Frame: at baseline
Questionnaires: PDI, SF-36
at baseline
Pain assessment (questionnaire)
Time Frame: at 3 months
questionnaire: numerical rating scale (NRS), central sensitization inventory (CSI), medical outcomes short form 36 health service (SF-36) Time Frame: after 18 treatment sessions
at 3 months
Pain assessment (questionnaire)
Time Frame: at 6 months
questionnaire: numerical rating scale (NRS), central sensitization inventory (CSI), medical outcomes short form 36 health service (SF-36)
at 6 months
Pain assessment (questionnaire)
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
questionnaire: numerical rating scale (NRS), central sensitization inventory (CSI), medical outcomes short form 36 health service (SF-36)
at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Pain assessment (physical testing)
Time Frame: at 3 months
Physical testing: pressure pain threshold (PTT), cold pressor test (CPT) Time Frame: after 18 treatment sessions
at 3 months
Pain assessment (physical testing)
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Physical testing: pressure pain threshold (PTT), cold pressor test (CPT)
at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Functional assessment (questionnaires)
Time Frame: at 1 week
Questionnaires: PDI, SF-36 Timeframe: after 3 treatment sessions (PDI)
at 1 week
Functional assessment (questionnaires)
Time Frame: at 3 months
Questionnaires: PDI, SF-36 Time Frame: after 18 treatment sessions
at 3 months
Functional assessment (questionnaires)
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Questionnaires: PDI, SF-36
at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Functional assessment (questionnaires)
Time Frame: at 6 months
Questionnaires: PDI, SF-36
at 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gray and white matter structure
Time Frame: at baseline

Gray and white matter structure and function in brain areas involved in pain processing and sensorimotor control.

Gray matter density - gray matter volumes - cortical thickness - surface area. Integrity of the white matter circuitry (tractography) - structural white matter connectivity - fractional anisotropy Intrinsic brain activity (cortex and nuclei) - functional connectivity

at baseline
Motor Control
Time Frame: at baseline
  1. Postural steadiness
  2. Habitual standing posture
  3. Spinal range of motion
  4. Sensorimotor control

i. Proprioception: position-reposition accuracy ii. Neuromuscular control (patients' ability to perform the skill of activation of specific, deep stabilizing muscles iii. Movement control of the spine

at baseline
Psychological correlates
Time Frame: at baseline
Psychological correlates: PCS, PVAQ, TSK, IPQ-R
at baseline
Neurophysiology of pain test (questionnaire)
Time Frame: at 1 week
Time Frame: after 3 treatment sessions Questionnaire: Dutch Neurophysiology of Pain Test (patient version)
at 1 week
Psychological correlates
Time Frame: at 1 week
Psychological correlates: PCS, PVAQ, TSK, IPQ-R Time Frame: after 3 treatment sessions
at 1 week
Psychological correlates
Time Frame: at 3 months
Psychological correlates: PCS, PVAQ, TSK, IPQ-R Time Frame: after 18 treatment sessions
at 3 months
Psychological correlates
Time Frame: at 6 months
Psychological correlates: PCS, PVAQ, TSK, IPQ-R
at 6 months
Psychological correlates
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Psychological correlates: PCS, PVAQ, TSK, IPQ-R
at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Muscle properties
Time Frame: at baseline
  1. Isometric muscle strength of spinal flexor and extensor muscles
  2. Endurance of spinal flexor and extensor muscles
at baseline
Muscle properties
Time Frame: at 3 months
  1. Isometric muscle strength of spinal flexor and extensor muscles
  2. Endurance of spinal flexor and extensor muscles

Time Frame: after 18 treatment sessions

at 3 months
Muscle properties
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
  1. Isometric muscle strength of spinal flexor and extensor muscles
  2. Endurance of spinal flexor and extensor muscles
at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Motor Control
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
  1. Postural steadiness
  2. Habitual standing posture
  3. Spinal range of motion
  4. Sensorimotor control

i. Proprioception: position-reposition accuracy ii. Neuromuscular control (patients' ability to perform the skill of activation of specific, deep stabilizing muscles iii. Movement control of the spine

at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Motor Control
Time Frame: at 3 months
  1. Postural steadiness
  2. Habitual standing posture
  3. Spinal range of motion
  4. Sensorimotor control

i. Proprioception: position-reposition accuracy ii. Neuromuscular control (patients' ability to perform the skill of activation of specific, deep stabilizing muscles iii. Movement control of the spine

Time Frame: after 18 treatment sessions

at 3 months
Gray and white matter structure
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)

Gray and white matter structure and function in brain areas involved in pain processing and sensorimotor control.

Gray matter density - gray matter volumes - cortical thickness - surface area. Integrity of the white matter circuitry (tractography) - structural white matter connectivity - fractional anisotropy Intrinsic brain activity (cortex and nuclei) - functional connectivity

at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Gray and white matter function
Time Frame: at 3 months

Gray and white matter structure and function in brain areas involved in pain processing and sensorimotor control.

Gray matter density - gray matter volumes - cortical thickness - surface area. Integrity of the white matter circuitry (tractography) - structural white matter connectivity - fractional anisotropy Intrinsic brain activity (cortex and nuclei) - functional connectivity

Time Frame: after 18 treatment sessions

at 3 months
Gray and white matter structure
Time Frame: at 3 months

Gray and white matter structure and function in brain areas involved in pain processing and sensorimotor control.

Gray matter density - gray matter volumes - cortical thickness - surface area. Integrity of the white matter circuitry (tractography) - structural white matter connectivity - fractional anisotropy Intrinsic brain activity (cortex and nuclei) - functional connectivity

Time Frame: after 18 treatment sessions

at 3 months
Gray and white matter function
Time Frame: at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)

Gray and white matter structure and function in brain areas involved in pain processing and sensorimotor control.

Gray matter density - gray matter volumes - cortical thickness - surface area. Integrity of the white matter circuitry (tractography) - structural white matter connectivity - fractional anisotropy Intrinsic brain activity (cortex and nuclei) - functional connectivity

at 12 months (except when no treatment effects would be found at 6 months: go/no go principle)
Gray and white matter function
Time Frame: at baseline

Gray and white matter structure and function in brain areas involved in pain processing and sensorimotor control.

Gray matter density - gray matter volumes - cortical thickness - surface area. Integrity of the white matter circuitry (tractography) - structural white matter connectivity - fractional anisotropy Intrinsic brain activity (cortex and nuclei) - functional connectivity

at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lieven Danneels, MD, PhD, University Ghent
  • Principal Investigator: Jo Nijs, MD, PhD, Vrije Universiteit Brussel

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

April 1, 2016

Study Completion (Actual)

April 1, 2016

Study Registration Dates

First Submitted

March 17, 2014

First Submitted That Met QC Criteria

March 26, 2014

First Posted (Estimate)

March 27, 2014

Study Record Updates

Last Update Posted (Actual)

May 8, 2017

Last Update Submitted That Met QC Criteria

May 3, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • EC/2013/1133

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Spinal Pain

Clinical Trials on usual care evidence-based physiotherapy

3
Subscribe